Comprehensive Transcriptomic Analysis of Single Cells and Bulk Samples Uncovers UBE2F as a Key Regulator of Ubiquitination Dysregulation in cDC1 During Sepsis - Top-Institutions - MDSpire

Comprehensive Transcriptomic Analysis of Single Cells and Bulk Samples Uncovers UBE2F as a Key Regulator of Ubiquitination Dysregulation in cDC1 During Sepsis

  • By

  • Cheng Li

  • Yiman Han

  • Zenglu Zheng

  • Chengya Huang

  • Zhiyun Liu

  • Jianwen Zhou

  • Rui Yang

  • Jingxiang Wu

  • April 22, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Immunology
    • Critical Care Medicine
    • Genomics

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Immunology
    • Critical Care Medicine
    • Systems Biology

  • #3

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Critical Care Medicine
    • Immunology
    • Molecular Biology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Immunology
    • Critical Care Medicine
    • Genomics

Original Source(s)

Comprehensive Transcriptomic Analysis of Single Cells and Bulk Samples Uncovers UBE2F as a Key Regulator of Ubiquitination Dysregulation in cDC1 During Sepsis

  • by Cheng Li, Yiman Han, Zenglu Zheng, Chengya Huang, Zhiyun Liu, Jianwen Zhou, Rui Yang, Jingxiang Wu

  • April 22, 2026

Related Content

Characteristics and outcomes of type 2 myocardial infarction in sepsis survivors

False-positive beta-glucan test due to beta-glucan component in sterile gauze during treatment of fungal sepsis: a case report

Dalbavancin Exposure Linked to Higher Success in Bacteremia

Higher day 22 concentrations were associated with improved outcomes, though findings remain exploratory